References
- Worms PM. The epidemiology of motor neuron disease: a review of recent studies. J Neurol Sci. 2001;191:3–9.
- Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota. Neurology. 2002;59:280–2.
- Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68: 141–5.
- Marin B, Gil J, Preux PM, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotroph Lateral Scler. 2009;10: 216–20.
- Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand. A 22-year study. Neurology. 2008;71:1889–95.
- Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
- Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7:217–26.
- del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
- Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006; 253:1428–36.
- Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
- Drory VE, Artmonov I. Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin: a clue to modifying genetic factors. J Neurol Sci. 2007;258:39–43.
- Zaldivar T, Gutierrez J, Lara G, Carbonara MS, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
- Yase Y, Yoshida S, Kihira T, Wakayama I, Kumoto J. Kii ALS dementia. Neuropathology. 2001;21:105–9.
- Plato CC, Garruto RM, Galasko D, Craig U-K, Plato M, Gamst A, . Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003;157:149–57.
- Kihira T, Yoshida S, Hironishi M, Miwa H, Okamoto K, Kondo T. Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler. 2005;6:155–63.
- Moriwaka F, Okumura H, Tashiro K, Hamada T, Matsumoto A, Matsumoto H, . Motor neuron disease and past poliomyelitis. Geographic study in Hokkaido, the northern-most island of Japan. J Neurol. 1993;240:13–6.
- Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, . Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15:239–45.
- Fong GCY, Cheng TS, Lam K, Cheng WK, Mok KY, Cheung CM, . An epidemiological study of motor neuron disease in Hong Kong. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:164–8.
- Lai CH, Tseng HF. Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology. 2008; 31:159–66.
- Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, . Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995–2001. J Epidemiol. 2005;15: 20–3.
- Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, . Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966–2005. J Neurol Sci. 2008;268:95–101.
- Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008;272:60–70.
- Fang DF, Zhang SS, Guo XY, Zeng Y, Yang Y, Zhou D, Shang HF. Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler. 2009;10:350–4.
- Malaysian National Census 2000. Department of Statistics, Malaysia.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl J Med. 1994;330:585–91.
- Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, . Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81: 385–90.
- Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009;10:324–31.
- Gil J, Vazquez MC, Ketzoian C, Perna A, Marin B, Preux PM, Couratier P. Prognosis of ALS: comparing data from the Limousin referral centre, France and a Uruguayan population. Amyotroph Lateral Scler. 2009;10:355–60.
- Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis/motor neuron disease (MND). Cochrane Database Syst Rev 2007; CD001447.
- Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays and Indians in Singapore. 1. Differences in mortality. J Epidemiol Community Health. 1990;44:24–8.
- Lee J, Heng D, Chia KS, Chew SK, Tian BY, Hughes K. Risk factors and incident coronary heart disease in Chinese, Malaya and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol. 2001;30:983–8.
- Patel DJ, Winterbotham M, Britt RP, Sutton GC, Bhatnagar D, Mackness MI, . Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet. 1995;345:405–9.
- Lechtzin N, Maragakis NJ, Kimball R, Busse A, Hoffman V, Clawson L. Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes. Amyotroph Lateral Scler. 2009;10:244–7.